Prof. Paulo E. Stanga is a Consultant Ophthalmologist and Vitreoretinal Surgeon for the Manchester Royal Eye Hospital (MREH) and Professor of Ophthalmology and Retinal Regeneration for the University of Manchester. Previous appointments: Lecturer in Ophthalmology for the University of Liverpool, Vitreoretinal Fellow at the Royal Liverpool University Hospital, Medical Retina Fellow at Moorfields Eye Hospital and Retina Research Fellow, New York Hospital, Cornell University Medical College, New York, USA.

Prof. Stanga is the Chairman of the MREH Research Steering Committee and specialises and leads in the development and introduction into clinical care of medical devices, both diagnostic/imaging and therapeutic, as well as new surgical techniques/therapies.

Prof. Stanga is a Developer, early adopter and introducer of new technology and therapies, which have ensured that MREH/CMFT are world pioneers and lead the country in the treatment of retinal diseases in adults and children. Now established as routine diagnostic and therapeutic approaches. MREH/CMFT are first to offer these therapies to its NHS patients with reduction of side effects and cost of care to the NHS.